The MammaTyper
®
Low risk Prediction (LRP)
For research use only!



Step 1, Select the instrument：
Select the instrument
The MammaTyper® LRP model can only be used with MammaTyper results generated on the LightCycler® 480 Instrument II, the Cobas z® 480 Analyzer (Roche), and the CFX96™ Real-Time PCR Detection System (Bio-Rad®)
Step 2, Enter the 40-ddcq value:
ERBB2 ESR1
PGR MKI67
By using this webpage, you acknowledge and agree to the terms below.
The information provided on this webpage regarding the MammaTyper® LRP model (“Model”) is intended for general informational purposes only and is not a substitute for professional medical advice. The model was developed for use in female patients with ESR1+/ERBB2- breast cancer to predict a low-risk Oncotype DX recurrence score (ODX-RS ≤ 25).
In using this website and the Model, you agree that neither Cerca Biotech GmbH (“Cerca Biotech”) nor any other party is or will be liable or otherwise responsible for any decision made or any action taken or not taken due to your use of any information contained in the Model. You are advised to consult with healthcare professionals before making any medical decisions or taking any actions or not taking any actions related to your healthcare problem or any other issue you might have.
No input data are or will be stored in the server of this webpage, which is located in Germany. In inputting data into the Model, you warrant compliance with all applicable data protection and human genetic resource regulations.
Step 3, Calculate the LRP results:
The MammaTyper® LRP model was developed and validated using samples with ODX-RS results from five centers in Germany and Switzerland (n=454) to predict a low-risk Oncotype DX recurrence score (ODX-RS ≤ 25) in female patients with ESR1+/ERBB2- breast cancer.
It demonstrates a high predictive value for identifying ODX-RS ≤ 25.
0.7039s